Related Experiment Videos
Mevalonate-derived proteins in liver regeneration
F Castellano1, G Bruscalupi, A Trentalance
1Dipartimento di Biologia Cellulare e dello Sviluppo, Universita di Roma I La Sapienza, Italy.
Bioscience Reports
|June 1, 1990
Summary
Mevalonate (MVA) synthesis post-hepatectomy is not for cholesterol but for proteins. A 26 kD nuclear protein suggests MVA
Area of Science:
- Biochemistry
- Cell Biology
- Hepatology
Background:
- Partial hepatectomy triggers liver regeneration.
- Mevalonate (MVA) is a key metabolic intermediate.
- The fate of MVA during liver regeneration is not fully understood.
Purpose of the Study:
- To investigate the utilization of mevalonate (MVA) in regenerating rat liver.
- To identify MVA-derived proteins during cell cycle progression.
Main Methods:
- Rat liver slices incubated with 5-3H-MVA post-partial hepatectomy.
- Analysis of labeled proteins from whole liver and purified nuclei.
- Protein identification via SDS-PAGE after delipidation.
Main Results:
- MVA was incorporated into proteins, not primarily cholesterol or dolichol, 16 hours post-hepatectomy.
- Numerous MVA-derived proteins were identified at 16 hours, decreasing by 24 hours.
- A highly labeled 26 kD peptide was found in the nucleus at 16 hours.
Conclusions:
- MVA is channeled into protein modification during early liver regeneration.
- The 26 kD nuclear peptide may play a role in cell cycle progression.
- This study elucidates a novel role for MVA in liver repair mechanisms.